Strength Seen in Marex Group PLC (MRX): Can Its 5.9% Jump Turn into More Strength?
Marex Group PLC (MRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Marex Group Impresses With Q4 Results
Marex Group is upgraded to a Buy following robust Q4 2025 results and strong momentum with large clients. MRX reported Q4 revenue up 38% to $572.1M and EPS up 50% to $1.14, exceeding expectations and driving 41.9% FY EPS growth. Agency/Execution segment now generates more revenue than the other three segments combined, with large-client revenue up 83% year-on-year.
Marex Group plc (MRX) Q4 2025 Earnings Call Transcript
Marex Group plc (MRX) Q4 2025 Earnings Call Transcript
Marex Group PLC (MRX) Q4 Earnings and Revenues Top Estimates
Marex Group PLC (MRX) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.76 per share a year ago.
Are You Looking for a Top Momentum Pick? Why Marex Group PLC (MRX) is a Great Choice
Does Marex Group PLC (MRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts See a 28.45% Upside in Marex Group PLC (MRX): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 28.5% in Marex Group PLC (MRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Marex Group: Q4 Volatility Could Help Them
The clearing business is doing well despite rate cuts, and the main weakness has been in some franchises in market making. In terms of outlook, profit growth seems to be expected even on an organic basis, and we think Q4 could look alright given the re-emergence of commodity and market volatility. We don't see an exceptional relative value case on first pass.
Marex Group plc (MRX) Q3 2025 Earnings Call Transcript
Marex Group plc ( MRX ) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants Adam Strachan - Head of Investor Relations Ian Lowitt - Group CEO & Executive Director Crispin Robert Irvin - CFO & Director Paolo Tonucci - Chief Strategist & CEO of Capital Markets Conference Call Participants Christopher Allen - Citigroup Inc., Research Division Benjamin Budish - Barclays Bank PLC, Research Division Alexander Blostein - Goldman Sachs Group, Inc., Research Division Daniel Fannon - Jefferies LLC, Research Division William Katz - TD Cowen, Research Division Carlos Gomez-Lopez - HSBC Global Investment Research Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the Marex Q3 earnings call. [Operator Instructions] I will now hand the conference over to Adam Strachan, Head of Investor Relations at Marex.
Marex Group PLC (MRX) Surpasses Q3 Earnings and Revenue Estimates
Marex Group PLC (MRX) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.76 per share a year ago.
Marex Group Set to Release Q3 Earnings: What's in Store for MRX?
MRX gears up for Q3 results with expected double-digit sales and profit growth, driven by strong client activity and strategic acquisitions.
Marex Group PLC (MRX) Earnings Expected to Grow: Should You Buy?
Marex Group PLC (MRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Delek sues Marex and BTX over $30 million refinery damage from tainted crude
Delek US Holdings has sued London-based Marex Group and Texas-based BTX Energy, accusing them of supplying contaminated crude oil that damaged one of its U.S. refineries and caused more than $30 million in losses.
